Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial (2019)
- Authors:
- Autor USP: BURDMANN, EMMANUEL DE ALMEIDA - FM
- Unidade: FM
- DOI: 10.1016/S0140-6736(19)30772-X
- Subjects: ENVELHECIMENTO; IDOSOS; DIABETES MELLITUS; NEFROPATIAS; MÉTODO DUPLO-CEGO; RESULTADO DE TRATAMENTO
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
- Licença: other-oa
-
ABNT
HEERSPINK, Hiddo J. L et al. Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial. Lancet, v. 393, n. 10184, p. 1937-1947, 2019Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(19)30772-X. Acesso em: 11 jun. 2024. -
APA
Heerspink, H. J. L., Parving, H. -H., Andress, D. L., Bakris, G., Correa-Rotter, R., Hou, F. -F., et al. (2019). Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial. Lancet, 393( 10184), 1937-1947. doi:10.1016/S0140-6736(19)30772-X -
NLM
Heerspink HJL, Parving H-H, Andress DL, Bakris G, Correa-Rotter R, Hou F-F, Kitzman DW, Kohan D, Makino H, Burdmann E de A. Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial [Internet]. Lancet. 2019 ; 393( 10184): 1937-1947.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/S0140-6736(19)30772-X -
Vancouver
Heerspink HJL, Parving H-H, Andress DL, Bakris G, Correa-Rotter R, Hou F-F, Kitzman DW, Kohan D, Makino H, Burdmann E de A. Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial [Internet]. Lancet. 2019 ; 393( 10184): 1937-1947.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1016/S0140-6736(19)30772-X - Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease
- Extracorporeal Treatment for Lithium Poisoning: systematic Review and Recommendations from the EXTRIP Workgroup
- Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial
- Peritoneal Dialysis in Acute Kidney Injury: Lessons Learned and Applied
- Acute kidney injury: global health alert
- Acute kidney injury: global health alert
- Predictive usefulness of unirary biomarkers for the identification of cyclosporine A induced nephrotoxicity in a rat model
- Cyclic Direct Radionuclide Cystography in the Diagnosis and Characterization of Vesicoureteral Reflux in Children and Adults
- Empatia em estudantes de Medicina: efeitos de um programa de gerenciamento do estresse
- Association of magnesium abnormalities at intensive care unit admission with kidney outcomes and mortality: a prospective cohort study
Informações sobre o DOI: 10.1016/S0140-6736(19)30772-X (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
